MedPath
NMPA Approval

Roxatidine Acetate Hydrochloride For Injection

国药准字H20244064

June 18, 2024

Drug Information

注射用盐酸罗沙替丁醋酸酯

注射剂

75mg(按C₁₉H₂₈N₂O₄•HCl计)

化学药品

June 18, 2024

Company Information

Applicant Company

海口国家高新区药谷工业园区药谷三横路2号

Manufacturing Company

海口国家高新区药谷工业园区药谷三横路2号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.